According to World Health Organization (WHO) one billion people worldwide are affected by one of the thousands of neurological disorders, including epilepsy, Alzheimer disease, strokes, and headaches. Neurological disorders also include brain injuries, neuroinfections, multiple sclerosis and Parkinson disease. A Review on Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics covers the major topics related to neurological disorders, current challenges in diagnosis and intervention. This book is organized into four distinct sections, starting with an introduction, providing a general overview of the epidemiology of neurological disorders, pathogenesis and management. The second section presents the aspects of brain diseases due to infection of bacteria, parasite, fungus and viruses. The third section discusses neurodegenerative disorders due to comorbid factors like diabetes, hypertension, hyperlipidemia and post traumatic brain injuries. The last section covers prevention through application of bioactive compounds and neuroprotective agents. - Epidemiology of neurological disorders and pathogenesis. - Explores neuroinflammation, ligand-receptors binding, and neurodegeneration. - Discusses aging and associated disorders in the onset of neurological disorders. - Neuropharmacology and the protective role of bioactive compounds in neuroprotection.

Communication disorders are impairments in the ability to receive, send, process, and comprehend hearing, language, and/or speech. While the number of culturally diverse populations is growing in the United States, speech-language pathologists and audiologists lack information on serving these culturally diverse populations appropriately and effectively. Cases on Communication Disorders in Culturally Diverse Populations is an essential research publication that provides culturally-competent hearing, language, and speech services and cases across age groups, communication disorders, and culturally diverse populations. These case studies offer a practical and detailed means for assisting professionals in providing culturally-appropriate speech, language, and hearing services. Highlighting various topics such as counseling, language learning, and genetics, this book is indispensable for speech-language pathologists, audiologists, counselors, administrators, academicians, researchers, practitioners, and students.

Diet and Nutrition in Neurological Disorders offers readers a comprehensive reference on the effect of dietary regimes in a wide variety of neurological diseases. With coverage of different types of diets, including Mediterranean or DASH, this broad coverage allows readers to learn about diets and their affect on specific disorders which may well be relevant to other conditions. This includes diseases such as Alzheimer's, Parkinson's, ALS, MS and severe neurological conditions such as brain injury, stroke, headache and migraine. This volume provides a platform for research on new dietary regimes and on future investigations of diet and nutrition. - Summarizes diet and nutrition research for a variety of neurological conditions - Contains chapter abstracts, key facts, dictionary and summary - Covers diet in Alzheimer's Parkinson's, ALS, MS, and more - Includes conditions like migraine, headache, stroke, and brain injury - Discusses the Mediterranean diet in the context of brain health

After graduating from Tripoli, Libya in 1990, Dr Benamer came to the United Kingdom in 1991 to further his training in medicine. He obtained the MRCP in 1994 and trained in neurology in Glasgow. He obtained a PhD and CCST in 2000 and was appointed a consultant neurologist in Wolverhampton and Birmingham the same year. He has been the lead neurologist in New Cross Hospital in Wolverhampton since 2006. Dr Benamer is a general neurologist with special interest in movement disorders. Dr Benamer is honorary clinical senior lecturer in Birmingham University and has an interest in medical education, in which he obtained a postgraduate certificate from Keele University in 2007. He has published more than 35 papers and two books. He is currently a senior editor of the Libyan Journal of Medicine. He was also an examiner of the MRCP Diploma from 2005 to 2009. Dr Benamer's publications relevant to the subject of the book: 1. Benamer HT. 2007. Neurological disorders in Libya: an overview. Neuroepidemiology 29:143-9 2. Benamer HT. 2008. The ancestry of LRRK2 Gly2019Ser parkinsonism. Lancet neurology 7:769-70; author reply 70-1 3. Benamer HT, de Silva R, Siddiqui KA, Grosset DG. 2008. Parkinson's disease in Arabs: a systematic review. Movement disorders: official journal of the Movement Disorder Society 23:1205-10 4. Benamer HT, Ahmed ES, Al-Din AS, Grosset DG. 2009. Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. Journal of the neurological sciences 278:1-4 5. Benamer HT, Grosset D. 2009. Stroke in Arab countries: a systematic literature review. Journal of the neurological sciences 284:18-23 6. Benamer HT, Grosset DG. 2009. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia 50:2301-4 7. Benamer HT, Shakir RA. 2009. The neurology map of the Arab world. Journal of the neurological sciences 285:10-2 8. Benamer HT. 2010. Neurology expertise and postgraduate training programmes in the Arab world: a survey. European neurology 64:313-8 9. Benamer HT, de Silva R. 2010. LRRK2 G2019S in the North African population: a review. European neurology 63:321-5 10. Benamer HT, Deleu D, Grosset D. 2010. Epidemiology of headache in Arab countries. The journal of headache and pain 11:1-3 11. Benamer HT. 2011. More epidemiological studies of neurological disorders are needed in the Arab countries. Neuroepidemiology 36:70.

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.

We would like to acknowledge Prof Rejko Krueger, from University of Luxembourg, who acted as a coordinator contributing to the preparation of the proposal for this Research Topic as part of the GEoPD.

Deep learning can provide more accurate results compared to machine learning. It uses layered algorithmic architecture to analyze data. It produces more accurate results since learning from previous results enhances its ability. The multi-layered nature of deep learning systems has the potential to classify subtle abnormalities in medical images, clustering patients with similar characteristics into risk-based cohorts, or highlighting relationships between symptoms and outcomes within vast quantities of unstructured data. Exploring this potential, Deep Learning for Smart Healthcare: Trends, Challenges and Applications is a reference work for researchers and academicians who are seeking new ways to apply deep learning algorithms in healthcare, including medical imaging and healthcare data analytics. It covers how deep learning can analyze a patient’s medical history efficiently to aid in recommending drugs and dosages. It discusses how deep learning can be applied to CT scans, MRI scans and ECGs to diagnose diseases. Other deep learning applications explored are extending the scope of patient record management, pain assessment, new drug design and managing the clinical trial process. Bringing together a wide range of research domains, this book can help to develop breakthrough applications for improving healthcare management and patient outcomes.

I am delighted to write a preface for this Celebratory eBook published in the Specialty Section Neuropharmacology, within the journal Frontiers in Pharmacology. The eBook delivers a compendium of high impact papers published previously in the journal over the last ten years; at the time of writing this collection of 20 papers has been viewed 700k times with over 75k downloads. Clearly this Section is delivering a useful resource to the scientific and medical research community! The scope of the Specialty Section Neuropharmacology is deliberately broad. We encourage submission of high quality and impactful papers in the field of neuropharmacology along the full length of the translational escalator; from cellular and molecular investigations to clinical trials. I believe this is a real strength of the Section and helps attract a diverse readership that builds the stakeholder network to promote further engagement of the Section with the research community. I have no doubt that this has contributed to the growth of the Section with submissions and accepted papers displaying 10-year (2009-2019) compound annual growth rates (CAGRs) of 58% and 78%, respectively. Vitaly, high quality, scientific rigour and impact are fundamental to a paper being accepted and this inevitably leads to a relatively high level of rejection, but the transparency of the review process means a fair decision is reached. Essential for the handling and considered review of submitted papers, the Specialty Section Neuropharmacology has a dynamic cohort of Associate Editors that have been selected carefully (81 at the time of writing) that represent the full spectrum of neuropharmacology as well as being widespread geographically around the globe. The Associate Editors are supported by nearly 500 Review Editors that ensures informed review – indeed the relatively open and interactive review process often adds considerably to the accepted version of the paper. As we celebrate the success of Frontiers in Pharmacology and the Specialty Section Neuropharmacology with this eBook, we must also recognise and be thankful for the hard work and dedication of those in the Editorial Office; their enthusiasm and willingness to help is outstanding and they form an integral component of the overall team that delivers the success. I look forward to further success for the Specialty Section Neuropharmacology. Happy reading! Professor Nicholas M. Barnes, FBPhS Specialty Chief Editor, Neuropharmacology

"This handbook is meant to guide you through post-acute holistic rehabilitation for patients with acquired brain injuries. Holistic milieu neurorehabilitation is defined as an interactive approach to treat the "whole person" using multimodal, individual and group therapies in the fields of neuropsychology/rehabilitation psychology, speech therapy, occupational therapy, physical therapy, recreational therapy, vocational counseling, nutrition, social work, and psychiatry. The patient and support network actively collaborate with the treatment team to ascertain and attain functional goals in the home and community, including productive school and work. Cognitive, language, communication, emotional, functional, interpersonal, spiritual, and quality of life aspects are addressed using restorative and compensatory interdisciplinary approaches. Superseding goals are enhanced fundamental life skills, well-being, and quality of life"--